BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) shares shot up 3.2% on Thursday . The stock traded as high as $9.48 and last traded at $9.44. 2,258 shares were traded during trading, an increase of 70% from the average session volume of 1,326 shares. The stock had previously closed at $9.15.
BioSyent Price Performance
The firm has a 50-day moving average of $8.99 and a 200-day moving average of $8.52.
BioSyent Dividend Announcement
The firm also recently declared a dividend, which was paid on Monday, December 15th. Stockholders of record on Monday, December 1st were issued a dividend of $0.0356 per share. This represents a dividend yield of 183.0%. The ex-dividend date of this dividend was Friday, November 28th.
BioSyent Company Profile
BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.
BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.
Featured Stories
- Five stocks we like better than BioSyent
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- Nvidia CEO Issues Bold Tesla Call
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
